Ready to Help Whenever You Need Us
We know who to talk to, where to find answers, and what steps you need to take. Let us put our 30 years of experience to work for you.

October 11, 2007— Over rising concerns about the safety of over-the-counter infant cold formulas, several manufacturers announced today that they were withdrawing the products from the drugstore shelves.
The recall came one week before the Food and Drug Administration plans to hold a hearing on the safety of OTC cough and cold medications for children. The FDA hearing is in response to doubts about the effectiveness of these products and mounting evidence the medications can cause serious complications, including severe hallucinations and agitation, seizures, high blood pressure, and heart and breathing problems that can be fatal in rare cases.
An FDA review prepared for next week's meeting describes dozens of cases of convulsions, heart problems, trouble breathing, neurological complications and other reactions, including at least 54 deaths involving decongestants and 69 deaths involving antihistamines. Most of the complications reported involved children younger than 2.
The recalls were announced by the drugs’ manufacturers, McNeil Consumer Healthcare, Novartis Consumer Health and Wyeth. This recall affects some 14 products, including: Dimetapp Decongestant Plus Cough Infant Drops, Tylenol Concentrated Infants' Drops Plus Cold, and Robitussin Infant Cough DM Drops.
Consumer Healthcare Products Association, a trade group for the makers, released the following list of the products that have been recalled:
Note - Do not change medications without first consulting your doctor.
Please fill out the form below to contact a Case Manager.
